TY - JOUR AU - Ford, E. S. AU - Giles, W. H. AU - Dietz, W. H. PY - 2002 DA - 2002// TI - Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey JO - JAMA VL - 287 UR - https://doi.org/10.1001/jama.287.3.356 DO - 10.1001/jama.287.3.356 ID - Ford2002 ER - TY - CHAP PY - 2003 DA - 2003// TI - Heart Disease and Stroke Statistics – 2004 Update BT - Dallas, Tex.: American Heart Association; © 2003 American Heart Association ID - ref2 ER - TY - JOUR AU - National Cholesterol Education Program (NCEP) Expert Panel on Detection, E. v. a. l. u. a. t. i. o. n. PY - 2002 DA - 2002// TI - Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report JO - Circulation VL - 106 ID - National Cholesterol Education Program (NCEP) Expert Panel on Detection2002 ER - TY - JOUR AU - Downs, J. R. AU - Clearfield, M. AU - Weis, S. AU - Whitney, E. AU - Shapiro, D. R. AU - Beere, P. A. AU - Langendorfer, A. AU - Stein, E. A. AU - Kruyer, W. AU - Gotto, A. M. PY - 1998 DA - 1998// TI - Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study JO - JAMA VL - 279 UR - https://doi.org/10.1001/jama.279.20.1615 DO - 10.1001/jama.279.20.1615 ID - Downs1998 ER - TY - JOUR AU - Shepherd, J. AU - Cobbe, S. M. AU - Ford, I. AU - Isles, C. G. AU - Lorimer, A. R. AU - MacFarlane, P. W. AU - McKillop, J. H. AU - Packard, C. J. PY - 1995 DA - 1995// TI - Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia JO - N Engl J Med VL - 333 UR - https://doi.org/10.1056/NEJM199511163332001 DO - 10.1056/NEJM199511163332001 ID - Shepherd1995 ER - TY - JOUR AU - Sacks, F. M. AU - Pfeffer, M. A. AU - Moye, L. A. AU - Rouleau, J. L. AU - Rutherford, J. D. AU - Cole, T. G. AU - Brown, L. AU - Warnica, J. W. AU - Arnold, J. M. AU - Wun, C. C. AU - Davis, B. R. AU - Braunwald, E. PY - 1996 DA - 1996// TI - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels JO - N Engl J Med VL - 335 UR - https://doi.org/10.1056/NEJM199610033351401 DO - 10.1056/NEJM199610033351401 ID - Sacks1996 ER - TY - JOUR PY - 1994 DA - 1994// TI - Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) JO - Lancet VL - 344 ID - ref7 ER - TY - JOUR PY - 1998 DA - 1998// TI - Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199811053391902 DO - 10.1056/NEJM199811053391902 ID - ref8 ER - TY - JOUR AU - Ballantyne, C. M. PY - 1998 DA - 1998// TI - Low-density lipoproteins and risk for coronary artery disease JO - Am J Cardiol VL - 82 UR - https://doi.org/10.1016/S0002-9149(98)00769-3 DO - 10.1016/S0002-9149(98)00769-3 ID - Ballantyne1998 ER - TY - JOUR AU - Grundy, S. M. AU - Cleeman, J. I. AU - Merz, C. N. AU - Brewer, H. B. AU - Clark, L. T. AU - Hunninghake, D. B. AU - Pasternak, R. C. AU - Smith, S. C. AU - Stone, N. J. PY - 2004 DA - 2004// TI - Coordinating Committee of the National Cholesterol Education Program; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines JO - Arterioscler Thromb Vasc Biol VL - 24 UR - https://doi.org/10.1161/01.ATV.0000133317.49796.0E DO - 10.1161/01.ATV.0000133317.49796.0E ID - Grundy2004 ER - TY - JOUR AU - Salisbury, B. G. AU - Davis, H. R. AU - Burrier, R. E. AU - Burnett, D. A. AU - Bowkow, G. AU - Caplen, M. A. AU - Clemmons, A. L. AU - Compton, D. S. AU - Hoos, L. M. AU - McGregor, D. G. PY - 1995 DA - 1995// TI - Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461 JO - Atherosclerosis VL - 115 UR - https://doi.org/10.1016/0021-9150(94)05499-9 DO - 10.1016/0021-9150(94)05499-9 ID - Salisbury1995 ER - TY - JOUR AU - Jeu, L. AU - Cheng, J. W. PY - 2003 DA - 2003// TI - Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor JO - Clin Ther VL - 25 UR - https://doi.org/10.1016/S0149-2918(03)80281-3 DO - 10.1016/S0149-2918(03)80281-3 ID - Jeu2003 ER - TY - JOUR AU - Nutescu, E. A. AU - Shapiro, N. L. PY - 2003 DA - 2003// TI - Ezetimibe: a selective cholesterol absorption inhibitor JO - Pharmacotherapy VL - 23 UR - https://doi.org/10.1592/phco.23.14.1463.31942 DO - 10.1592/phco.23.14.1463.31942 ID - Nutescu2003 ER - TY - JOUR AU - Van Heek, M. AU - France, C. F. AU - Compton, D. S. AU - McLeod, R. L. AU - Yumibe, N. P. AU - Alton, K. B. AU - Sybertz, E. J. AU - Davis, H. R. PY - 1997 DA - 1997// TI - In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH5 in the rat and rhesus monkey through the identification of the active metabolites of SCH48461 JO - J Pharmacol Exp Ther VL - 283 ID - Van Heek1997 ER - TY - JOUR AU - Courtney, R. D. AU - Kosoglou, T. AU - Statkevich, P. PY - 2002 DA - 2002// TI - Effect of food on the oral bioavailability of ezetimibe JO - Clin Pharmacol Ther VL - 71 ID - Courtney2002 ER - TY - STD TI - Zetia [package insert]. North Wales, Pa: Merck/Schering Plough Pharmaceuticals. 2003. ID - ref16 ER - TY - JOUR AU - Manel, B. a. r. b. a. n. o. j. AU - Rosa, A. n. t. o. n. i. j. o. a. n. AU - Adelaida, M. o. r. t. e. AU - Josep Ma, G. r. i. n. y. ó. AU - Ricard, S. o. l. à. AU - Joaquim, V. a. l. l. è. s. AU - Concepció, P. e. r. a. i. r. e. AU - José, C. o. r. d. e. r. o. A. AU - Ana, M. u. ñ. o. z. AU - Francesc, J. a. n. é. AU - Rossend, O. b. a. c. h. PY - 2002 DA - 2002// TI - Pharmacokinetics of Ezetimibe in subjects with normal renal function or severe chronic renal insufficiency JO - Clin Pharmacol Ther VL - 71 ID - Manel2002 ER - TY - JOUR AU - Harumi, T. a. k. a. h. a. s. h. i. AU - Shiro, I. s. h. i. k. a. w. a. AU - Shinichi, N. o. m. o. t. o. AU - Yoshiyuki, N. i. s. h. i. g. a. k. i. AU - Fumitaka, A. n. d. o. AU - Toshitaka, K. a. s. h. i. m. a. AU - Sosuke, K. i. m. u. r. a. AU - Madoka, K. a. n. a. m. o. r. i. AU - Hirotoshi, E. c. h. i. z. e. n. PY - 2001 DA - 2001// TI - Ezetimibe does not affect the pharmacokinetics or pharmacodynamics of warfarin JO - Clin Pharmacol Ther VL - 69 ID - Harumi2001 ER - TY - JOUR AU - Reyderman, L. AU - Kosoglou, T. AU - Statkevich, P. PY - 2001 DA - 2001// TI - No pharmacokinetic drug interaction between ezetimibe and lovastatin JO - Clin Pharmacol Ther VL - 69 UR - https://doi.org/10.1067/mcp.2001.112680 DO - 10.1067/mcp.2001.112680 ID - Reyderman2001 ER - TY - JOUR AU - Zhu, Y. AU - Statkevich, F. '. AU - Kosoglou, T. PY - 2001 DA - 2001// TI - Lack of pharmacokinetic interaction between ezetimibe and atorvastatin JO - Clin Pharmacol Ther VL - 69 ID - Zhu2001 ER - TY - JOUR AU - Fux, R. AU - Morike, K. AU - Gundel, U. F. AU - Hartmann, R. AU - Gleiter, C. H. PY - 2004 DA - 2004// TI - Ezetimibe and statin-associated myopathy JO - Ann Intern Med VL - 140 UR - https://doi.org/10.7326/0003-4819-140-8-200404200-00034 DO - 10.7326/0003-4819-140-8-200404200-00034 ID - Fux2004 ER - TY - JOUR AU - Bays, H. E. AU - Moore, P. B. AU - Drehobl, M. A. AU - Rosenblatt, S. AU - Toth, P. D. AU - Dujovne, C. A. AU - Knopp, R. H. AU - Lipka, L. J. AU - Lebeaut, A. P. AU - Yang, B. AU - Mellars, L. E. AU - Cuffie-Jackson, C. AU - Veltri, E. P. PY - 2001 DA - 2001// TI - Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies JO - Clin Ther VL - 23 UR - https://doi.org/10.1016/S0149-2918(01)80102-8 DO - 10.1016/S0149-2918(01)80102-8 ID - Bays2001 ER - TY - JOUR AU - Knopp, R. H. AU - Dujovne, C. A. AU - Le Beaut, A. AU - Lipka, L. J. AU - Suresh, R. AU - Veltri, E. P. PY - 2003 DA - 2003// TI - Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase III clinical studies JO - Int J Clin Pract VL - 57 ID - Knopp2003 ER - TY - JOUR AU - Dujovne, C. A. AU - Ettinger, M. P. AU - McNeer, J. F. AU - Lipka, L. J. AU - LeBeaut, A. P. AU - Suresh, R. AU - Yang, B. AU - Veltri, E. P. PY - 2002 DA - 2002// TI - Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia JO - Am J Cardiol VL - 90 UR - https://doi.org/10.1016/S0002-9149(02)02798-4 DO - 10.1016/S0002-9149(02)02798-4 ID - Dujovne2002 ER - TY - JOUR AU - Kerzner, B. AU - Corbelli, J. AU - Sharp, S. AU - Lipka, L. J. AU - Melani, L. AU - LeBeaut, A. AU - Suresh, R. AU - Mukhopadhyay, P. AU - Veltri, E. P. PY - 2003 DA - 2003// TI - Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia JO - Am J Cardiol VL - 91 UR - https://doi.org/10.1016/S0002-9149(02)03236-8 DO - 10.1016/S0002-9149(02)03236-8 ID - Kerzner2003 ER - TY - JOUR AU - Al-Shaer, M. H. PY - 2004 DA - 2004// TI - The Effects of Ezetimibe on the LDL-Cholesterol Particle Number JO - Cardiovasc Drugs Ther VL - 18 UR - https://doi.org/10.1023/B:CARD.0000041253.85861.24 DO - 10.1023/B:CARD.0000041253.85861.24 ID - Al-Shaer2004 ER - TY - JOUR AU - Foley, K. A. AU - Simpson, R. J. AU - Crouse, J. R. AU - Weiss, T. W. AU - Markson, L. E. AU - Alexander, C. M. PY - 2003 DA - 2003// TI - Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events JO - Am J Cardiol VL - 92 UR - https://doi.org/10.1016/S0002-9149(03)00474-0 DO - 10.1016/S0002-9149(03)00474-0 ID - Foley2003 ER - TY - JOUR PY - 2002 DA - 2002// TI - Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT) JO - JAMA VL - 288 UR - https://doi.org/10.1001/jama.288.23.2998 DO - 10.1001/jama.288.23.2998 ID - ref28 ER - TY - JOUR AU - Roberts, W. C. PY - 1997 DA - 1997// TI - The rule of 5 and the rule of 7 in lipid-lowering by statin drugs JO - Am J Cardiol. VL - 80 UR - https://doi.org/10.1016/S0002-9149(97)00298-1 DO - 10.1016/S0002-9149(97)00298-1 ID - Roberts1997 ER - TY - JOUR AU - Gagne, C. AU - Bays, H. E. AU - Weiss, S. R. AU - Mata, P. AU - Quinto, K. AU - Melino, M. AU - Cho, M. AU - Musliner, T. A. AU - Gumbiner, B. PY - 2002 DA - 2002// TI - Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia JO - Am J Cardiol VL - 90 UR - https://doi.org/10.1016/S0002-9149(02)02774-1 DO - 10.1016/S0002-9149(02)02774-1 ID - Gagne2002 ER - TY - JOUR AU - Gagne, C. AU - Gaudet, D. AU - Bruckert, E. AU - Gagne, C. AU - Gaudet, D. AU - Bruckert, E. PY - 2002 DA - 2002// TI - Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia JO - Circulation VL - 105 UR - https://doi.org/10.1161/01.CIR.0000018744.58460.62 DO - 10.1161/01.CIR.0000018744.58460.62 ID - Gagne2002 ER - TY - JOUR AU - Bruckert, E. AU - Giral, P. AU - Tellier, P. PY - 2003 DA - 2003// TI - Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption JO - Circulation. VL - 107 UR - https://doi.org/10.1161/01.CIR.0000072345.98581.24 DO - 10.1161/01.CIR.0000072345.98581.24 ID - Bruckert2003 ER - TY - JOUR AU - Davidson, M. H. AU - McGarry, T. AU - Bettis, R. AU - Melani, L. AU - Lipka, L. J. AU - LeBeaut, A. P. AU - Suresh, R. AU - Sun, S. AU - Veltri, E. P. PY - 2002 DA - 2002// TI - Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia JO - J Am Coll Cardiol VL - 40 UR - https://doi.org/10.1016/S0735-1097(02)02610-4 DO - 10.1016/S0735-1097(02)02610-4 ID - Davidson2002 ER - TY - JOUR AU - Kosoglou, T. AU - Statkevich, P. AU - Fruchart, J. C. AU - Pember, L. J. AU - Reyderman, L. AU - Cutler, D. L. AU - Guillaume, M. AU - Maxwell, S. E. AU - Veltri, E. P. PY - 2004 DA - 2004// TI - Pharmacodynamic and pharmacokinetic interaction between fenofibrate and ezetimibe JO - Curr Med Res Opin VL - 20 UR - https://doi.org/10.1185/030079903125004277 DO - 10.1185/030079903125004277 ID - Kosoglou2004 ER - TY - JOUR AU - Lu, K. AU - Lee, M. H. AU - Hazard, S. AU - Brooks-Wilson, A. AU - Hidaka, H. AU - Kojima, H. AU - Ose, L. AU - Stalenhoef, A. F. AU - Mietinnen, T. AU - Bjorkhem, I. AU - Bruckert, E. AU - Pandya, A. AU - Brewer, H. B. AU - Salen, G. AU - Dean, M. AU - Srivastava, A. AU - Patel, S. B. PY - 2001 DA - 2001// TI - Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by abcg5 and abcg8, respectively JO - Am J Hum Genet VL - 69 UR - https://doi.org/10.1086/321294 DO - 10.1086/321294 ID - Lu2001 ER - TY - JOUR AU - Bhattacharyya, A. K. AU - Connor, W. E. PY - 1974 DA - 1974// TI - Beta-sitosterolemia and xanthomatosis: a newly described lipid storage disease in two sisters JO - J Clin Invest VL - 53 UR - https://doi.org/10.1172/JCI107640 DO - 10.1172/JCI107640 ID - Bhattacharyya1974 ER - TY - JOUR AU - Nguyen, L. B. AU - Shefer, S. AU - Salen, G. AU - Ness, G. C. AU - Tint, G. S. AU - Zaki, F. G. AU - Rani, I. PY - 1990 DA - 1990// TI - A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis JO - J Clin Invest VL - 86 UR - https://doi.org/10.1172/JCI114794 DO - 10.1172/JCI114794 ID - Nguyen1990 ER - TY - JOUR AU - Wang, C. AU - Lin, H. J. AU - Chan, T. K. AU - Salen, G. AU - Chan, W. C. AU - Tse, T. F. PY - 1981 DA - 1981// TI - A unique patient with coexisting cerebrotendinous xanthomatosis and beta-sitosterolemia JO - Am J Med VL - 71 UR - https://doi.org/10.1016/0002-9343(81)90134-0 DO - 10.1016/0002-9343(81)90134-0 ID - Wang1981 ER - TY - JOUR AU - Miettinen, T. A. PY - 1980 DA - 1980// TI - Phytosterolemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis JO - Europ J Clin Invest VL - 10 UR - https://doi.org/10.1111/j.1365-2362.1980.tb00320.x DO - 10.1111/j.1365-2362.1980.tb00320.x ID - Miettinen1980 ER - TY - JOUR AU - Kwiterovich, P. O. AU - Bachorik, P. S. AU - Smith, H. H. AU - McKusick, V. A. AU - Connor, W. E. AU - Teng, B. AU - Sniderman, A. D. PY - 1981 DA - 1981// TI - Hyperapobetalipoproteinaemia in two families with xanthomas and phytosterolaemia JO - Lancet VL - I UR - https://doi.org/10.1016/S0140-6736(81)91850-X DO - 10.1016/S0140-6736(81)91850-X ID - Kwiterovich1981 ER - TY - JOUR AU - Salen, G. AU - Horak, I. AU - Rothkopf, M. AU - Cohen, J. L. AU - Speck, J. AU - Tint, G. S. AU - Shore, V. AU - Dayal, B. AU - Chen, T. AU - Shefer, S. PY - 1985 DA - 1985// TI - Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis JO - J Lipid Res VL - 26 ID - Salen1985 ER - TY - JOUR AU - Salen, G. AU - von Bergmann, K. AU - Lutjohann, D. AU - Kwiterovich, P. AU - Kane, J. AU - Patel, S. B. AU - Musliner, T. AU - Stein, P. AU - Musser, B. PY - 2004 DA - 2004// TI - Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia JO - Circulation VL - 109 UR - https://doi.org/10.1161/01.CIR.0000116766.31036.03 DO - 10.1161/01.CIR.0000116766.31036.03 ID - Salen2004 ER - TY - JOUR AU - Huff, M. W. PY - 2003 DA - 2003// TI - Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis JO - Can J Clin Pharmacol VL - Winter; 10 ID - Huff2003 ER - TY - JOUR AU - Evans, M. AU - Roberts, A. AU - Rees, A. PY - 2002 DA - 2002// TI - The future direction of cholesterol-lowering therapy JO - Curr Opin Lipidol VL - 13 UR - https://doi.org/10.1097/00041433-200212000-00010 DO - 10.1097/00041433-200212000-00010 ID - Evans2002 ER - TY - JOUR AU - Sager, P. T. AU - Melani, L. AU - Lipka, L. AU - Strony, J. AU - Yang, B. AU - Suresh, R. AU - Veltri, E. PY - 2003 DA - 2003// TI - Ezetimibe Study Group. Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein JO - American Journal of Cardiology VL - 92 UR - https://doi.org/10.1016/j.amjcard.2003.08.048 DO - 10.1016/j.amjcard.2003.08.048 ID - Sager2003 ER - TY - JOUR AU - Ballantyne, C. M. AU - Houri, J. AU - Notarbartolo, A. AU - Melani, L. AU - Lipka, L. J. AU - Suresh, R. AU - Sun, S. AU - LeBeaut, A. P. AU - Sager, P. T. AU - Veltri, E. P. PY - 2003 DA - 2003// TI - Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial JO - Circulation VL - 107 UR - https://doi.org/10.1161/01.CIR.0000068312.21969.C8 DO - 10.1161/01.CIR.0000068312.21969.C8 ID - Ballantyne2003 ER -